Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.33 USD | +1.34% | -0.44% | +0.89% |
04-05 | Arbutus Biopharma Obtains Favorable Court Order in Moderna Patent Lawsuit | MT |
04-04 | Moderna Suffers Setback in Lawsuit by Arbutus | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.89% | 9.13B | |
+30.21% | 588B | |
-3.42% | 364B | |
+18.02% | 326B | |
+4.27% | 285B | |
+14.87% | 239B | |
+9.69% | 210B | |
-7.61% | 200B | |
+8.12% | 167B | |
-1.42% | 161B |
- Stock Market
- Equities
- ROIV Stock
- News Roivant Sciences Ltd.
- JPMorgan Adjusts Roivant Sciences Price Target to $14 From $12, Maintains Overweight Rating